TTR and Alzheimer disease: Additionally, two possible substrates of TTR have been identified in the central nervous system: neuropeptide Y [44], a molecule with anti-inflammatory and neuroprotective functions [45], and amyloid β peptide (Aβ), which plays a key role in AD pathogenesis.